Genetic testing transforms inherited eye disease care, but expert interpretation matters—learn why false negatives and new gene therapies reshape retina practice.
Ian C. Han, MD
Advertisement
Articles by Ian C. Han, MD
Ian C. Han, MD, shares his thoughts on the value of anecdotal evidence in our winter 2024 editorial.
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on Modern Retina
1
StemSight gains patent for off-the-shelf limbal stem cell platform patent milestone for STE-101
2
Altered ipRGC circuits and function may translate to disrupted sleep and circadian rhythms in Alzheimer’s disease
3
CTS 2026: OTX-TKI demonstrates superiority over aflibercept in wet AMD—what the SOL-1 data mean for retina practice
4
Ranluspec FDA approval: Cyrus Karkaria, PhD, on biosimilar access, prefilled syringes, and long-term switching confidence
5